https://www.healthcarenewsnetherlands.com/article/913608564-matisse-pharmaceuticals-receives-fda-ind-clearance-for-isupartob-sodium Healthcare News Netherlands en PressRelease 2026-05-19T12:00:00+00:00 Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium https://ml-eu.globenewswire.com/media/463f1f88-9a63-4f6b-bcf0-da0f4352b838/medium/matisse-production-image.jpg https://www.healthcarenewsnetherlands.com/article/913562075-khondrion-announces-first-patient-dosed-in-phase-ii-study-targeting-debilitating-post-covid-fatigue Healthcare News Netherlands en PressRelease 2026-05-19T06:00:00+00:00 Khondrion Announces First Patient Dosed in Phase II Study Targeting Debilitating Post-COVID Fatigue https://ml-eu.globenewswire.com/media/MzNlYmI3ODQtY2JmMi00OWJmLWI3NmUtNGY1ODY5ODE0MDJhLTEzMjMxNjctMjAyNi0wNS0xOS1lbg==/tiny/Khondrion-B-V-.png https://www.healthcarenewsnetherlands.com/article/913562147-onward-medical-to-announce-first-quarter-2026-results-on-may-26-2026 Healthcare News Netherlands en PressRelease 2026-05-19T05:30:00+00:00 ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png